Shenzhen New Industries Biomedical Engineering Co., Ltd.
300832
Clasificación en acciones
#2881
Shenzhen New Industries Biomedical Engineering Co., Ltd., engages in the... Shenzhen New Industries Biomedical Engineering Co., Ltd., engages in the research, development, production, and sale of clinical laboratory instruments and in vitro diagnostic reagents to hospitals in China and internationally. It offers immunoassay machine, biochemistry/electrolyte, integrated system, lab automation, molecular diagnostics, hemolumi and rapid test solutions. The company was founded in 1995 and is based in Shenzhen, China.
Precio por acción
$8.03
Capitalización bursátil
$6.31B
Cambio (1 día)
1.07%
Cambio (1 año)
-8.04%
País
CN
Comercio Shenzhen New Industries Biomedical Engineering Co., Ltd. (300832)
Categoría
Healthcare
Ganancias de Shenzhen New Industries Biomedical Engineering Co., Ltd. (300832)
Ganancias en Jun 2026 TTM: $294.96M
Secondo gli ultimi rapporti finanziari di Shenzhen New Industries Biomedical Engineering Co., Ltd., gli utili attuali della società sono $294.96M. Nel 2024, la società ha registrato un utile di $286.77M, un aumento con respecto a agli utili del 2023, che erano di $267.43M. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de Shenzhen New Industries Biomedical Engineering Co., Ltd. desde 2012 hasta 2026
Ganancias al final de cada año
| Año | Ganancias | Cambiar |
|---|---|---|
| 2026 (TTM) | $294.96M | 11.23% |
| 2025 | $265.17M | -7.53% |
| 2024 | $286.77M | 7.23% |
| 2023 | $267.43M | 22.88% |
| 2022 | $217.63M | 21.82% |
| 2021 | $178.66M | 6.41% |
| 2020 | $167.89M | 30.12% |
| 2019 | $129.03M | 9.95% |
| 2018 | $117.35M | 21.27% |
| 2017 | $96.77M | 27.14% |
| 2016 | $76.11M | 69.74% |
| 2015 | $44.84M | -6.42% |
| 2014 | $47.91M | 76.41% |
| 2013 | $27.16M | 94.24% |
| 2012 | $13.98M | 0.00% |
Ganancias de empresas similares o competidoras
| Empresa | Ganancias | Diferencia de ganancias | País |
|---|---|---|---|
| $6.56B | 2,124.73% |
US
|
|
| $6.60B | 2,138.63% |
IE
|
|
| $5.15B | 1,645.34% |
US
|
|
| $3.86B | 1,209.00% |
US
|
|
| $3.25B | 1,001.86% |
DE
|
